BRIEF-Roche expects Tamiflu sales in 2017 to drop following patent expiry
* Ceo says sees no "direction change" in attractiveness of u.s. Market under president trump [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: trump, president, under, Market, attractiveness, change", "direction, expiry, patent, following, sales, Tamiflu, expects, BRIEF-Roche
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/7IjTc6kU-Rs/idUSFWN1FM0AA